Cargando…

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2

The dopamine D(4) receptor (D(4)R) is expressed in the retina, prefrontal cortex, and autonomic nervous system and has been implicated in attention deficit hyperactivity disorder (ADHD), substance use disorders, and erectile dysfunction. D(4)R has also been investigated as a target for antipsychotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burström, Viktor, Ågren, Richard, Betari, Nibal, Valle-León, Marta, Garro-Martínez, Emilio, Ciruela, Francisco, Sahlholm, Kristoffer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911804/ https://www.ncbi.nlm.nih.gov/pubmed/36778010 http://dx.doi.org/10.3389/fphar.2023.1087171

Ejemplares similares

Voltage-Dependent Dopamine Potency at D(1)-Like Dopamine Receptors
por: Ågren, Richard, et al.
Publicado: (2020)

The Beta-Arrestin-Biased Dopamine D(2) Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
por: Ågren, Richard, et al.
Publicado: (2018)

Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations
por: Betari, Nibal, et al.
Publicado: (2020)

Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
por: Gray, David L., et al.
Publicado: (2018)

Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D(2) Receptor
por: Ågren, Richard, et al.
Publicado: (2021)

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics
por: Ågren, Richard, et al.
Publicado: (2023)

Dopamine D(2) Receptor Agonist Binding Kinetics—Role of a Conserved Serine Residue
por: Ågren, Richard, et al.
Publicado: (2021)

Striatal Dopamine D(2)-Muscarinic Acetylcholine M(1) Receptor–Receptor Interaction in a Model of Movement Disorders
por: Crans, René A. J., et al.
Publicado: (2020)

Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation
por: Donthamsetti, Prashant, et al.
Publicado: (2018)

Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders
por: Crans, René A. J., et al.
Publicado: (2022)

Pridopidine Reverses Phencyclidine-Induced Memory Impairment
por: Sahlholm, Kristoffer, et al.
Publicado: (2018)

Antipsychotics with similar association kinetics at dopamine D(2) receptors differ in extrapyramidal side-effects
por: Zeberg, Hugo, et al.
Publicado: (2018)

Ligand with Two Modes of Interaction with the Dopamine D(2) Receptor–An Induced-Fit Mechanism of Insurmountable Antagonism
por: Ågren, Richard, et al.
Publicado: (2020)

Decreased striatal adenosine A(2A)-dopamine D(2) receptor heteromerization in schizophrenia
por: Valle-León, Marta, et al.
Publicado: (2020)

G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D(2) Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation
por: Sánchez-Soto, Marta, et al.
Publicado: (2023)

Role of Beta-Arrestin 2 Downstream of Dopamine Receptors in the Basal Ganglia
por: Del’Guidice, Thomas, et al.
Publicado: (2011)

The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor
por: Al-Sabah, Suleiman, et al.
Publicado: (2020)

Defining the roles of arrestin2 and arrestin3 in vasoconstrictor receptor desensitization in hypertension
por: Willets, Jonathon M., et al.
Publicado: (2015)

Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods
por: Hsieh, Chia-Ju, et al.
Publicado: (2021)

Continuous Activation of Dopamine Receptors Alleviates LPS-Induced Liver Injury in Mice via β-arrestin2 Dependent Akt/NF-κB Pathway
por: Li, Mingan, et al.
Publicado: (2022)

A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D(2)-Like Receptors
por: Forster, Lisa, et al.
Publicado: (2020)

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2014)

The Dopamine D5 Receptor Is Involved in Working Memory
por: Carr, Gregory V., et al.
Publicado: (2017)

Roles of Dopamine D(2) Receptor Subregions in Interactions with β-Arrestin2
por: Zhang, Xiaohan, et al.
Publicado: (2016)

LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling
por: Mustafá, Emilio R., et al.
Publicado: (2021)

Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A(2A)-Dopamine D(2) Receptor Heterotetramers and Adenylyl Cyclase
por: Ferré, Sergi, et al.
Publicado: (2018)

Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D(2) Receptor
por: Silva, Rafaela R., et al.
Publicado: (2019)

Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
por: Wang, Yuhan, et al.
Publicado: (2017)

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
por: Zhao, Fangyi, et al.
Publicado: (2022)

Visualization of arrestin recruitment by a G Protein-Coupled Receptor
por: Shukla, Arun K., et al.
Publicado: (2014)

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
por: Martel, Jean Claude, et al.
Publicado: (2020)

Amphetamine Promotes Cortical Up State in Part Via Dopamine Receptors
por: Shen, Guofang, et al.
Publicado: (2021)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions
por: Gao, Yonglin, et al.
Publicado: (2015)

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
por: Maramai, Samuele, et al.
Publicado: (2016)

Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review
por: Elias, Murad, et al.
Publicado: (2023)

Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D(1) Dopamine Receptor and Their Roles in Modulating β-Arrestin Binding and Activation
por: Moritz, Amy E., et al.
Publicado: (2023)

Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay
por: Saecker, Luisa, et al.
Publicado: (2023)

Editorial: G Protein-Coupled Receptor Kinases (GRKs) and β-Arrestins: New Insights Into Disease Regulators
por: Hattori, Yuichi, et al.
Publicado: (2020)

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
por: Coyle, Joseph T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tm9makd7tlies2fgje9m5b51np